ArticleCardiovascular diabetology2018

Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy.

Concetta Irace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.